AU2006206525A1 - Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases - Google Patents
Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases Download PDFInfo
- Publication number
- AU2006206525A1 AU2006206525A1 AU2006206525A AU2006206525A AU2006206525A1 AU 2006206525 A1 AU2006206525 A1 AU 2006206525A1 AU 2006206525 A AU2006206525 A AU 2006206525A AU 2006206525 A AU2006206525 A AU 2006206525A AU 2006206525 A1 AU2006206525 A1 AU 2006206525A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- pct
- optionally substituted
- mmol
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64555205P | 2005-01-20 | 2005-01-20 | |
| US60/645,552 | 2005-01-20 | ||
| PCT/US2006/001747 WO2006078724A2 (en) | 2005-01-20 | 2006-01-19 | Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2006206525A2 AU2006206525A2 (en) | 2006-07-27 |
| AU2006206525A1 true AU2006206525A1 (en) | 2006-07-27 |
Family
ID=36692822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006206525A Abandoned AU2006206525A1 (en) | 2005-01-20 | 2006-01-19 | Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7553842B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1838316A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2008528491A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2006206525A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2601380A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MX2007008662A (cg-RX-API-DMAC10.html) |
| TW (1) | TW200637552A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2006078724A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0904540D0 (en) * | 2009-03-17 | 2009-04-29 | Biotica Tech Ltd | Novel compounds and methods for their production |
| GB0917817D0 (en) * | 2009-10-12 | 2009-11-25 | Biotica Tech Ltd | Novel compounds and methods for their production |
| GB0917816D0 (en) * | 2009-10-12 | 2009-11-25 | Biotica Tech Ltd | Novel compounds and methods for their production |
| IT1401451B1 (it) * | 2010-06-10 | 2013-07-26 | Chemi Spa | Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo. |
| US9814703B2 (en) | 2013-11-14 | 2017-11-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating cancer by activation of BMP signaling |
| EP3433259B1 (en) * | 2016-03-24 | 2021-06-30 | The Administrators of The Tulane Educational Fund | Conjugates of tacrolimus, their compositions, and their uses |
| CA3043575A1 (en) * | 2016-11-10 | 2018-05-17 | Novartis Ag | Bmp potentiators |
| CN108148032B (zh) * | 2018-03-01 | 2019-12-13 | 北京海步医药科技股份有限公司 | 一种3,4-二氢-2h-1-苯并吡喃-2-羧酸类化合物的制备方法及其应用 |
| CN119751235A (zh) * | 2019-01-23 | 2025-04-04 | 约翰霍普金斯大学 | 非免疫抑制性fk506类似物及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2245891A (en) | 1990-07-09 | 1992-01-15 | Fujisawa Pharmaceutical Co | Tricyclo compounds |
| US5565560A (en) | 1991-05-13 | 1996-10-15 | Merck & Co., Inc. | O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity |
| US5457111A (en) * | 1991-09-05 | 1995-10-10 | Abbott Laboratories | Macrocyclic immunomodulators |
| US5563172A (en) * | 1991-09-05 | 1996-10-08 | Abbott Laboratories | Macrocyclic amide and urea immunomodulators |
| US5252732A (en) * | 1991-09-09 | 1993-10-12 | Merck & Co., Inc. | D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity |
| US5284877A (en) * | 1992-06-12 | 1994-02-08 | Merck & Co., Inc. | Alkyl and alkenyl macrolides having immunosuppressive activity |
| WO1994021634A1 (en) * | 1993-03-17 | 1994-09-29 | Abbott Laboratories | Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators |
| US5457194A (en) * | 1993-03-17 | 1995-10-10 | Abbott Laboratories | Substituted aliphatic amine-containing macrocyclic immunomodulators |
| WO1994021254A1 (en) * | 1993-03-17 | 1994-09-29 | Abbott Laboratories | Substituted alicyclic amine-containing macrocyclic immunomodulators |
| WO1994021642A1 (en) * | 1993-03-17 | 1994-09-29 | Abbott Laboratories | Macrocyclic amide and urea immunomodulators |
| US6093615A (en) * | 1994-08-15 | 2000-07-25 | Micron Technology, Inc. | Method of fabricating a contact structure having a composite barrier layer between a platinum layer and a polysilicon plug |
| DE19859467C2 (de) * | 1998-12-22 | 2002-11-28 | Steag Micro Tech Gmbh | Substrathalter |
| US6569867B2 (en) * | 1999-10-01 | 2003-05-27 | Kosan Biosciences, Inc. | Polyketide derivatives |
-
2006
- 2006-01-19 AU AU2006206525A patent/AU2006206525A1/en not_active Abandoned
- 2006-01-19 CA CA002601380A patent/CA2601380A1/en not_active Abandoned
- 2006-01-19 EP EP06718768A patent/EP1838316A4/en not_active Withdrawn
- 2006-01-19 TW TW095102047A patent/TW200637552A/zh unknown
- 2006-01-19 US US11/334,858 patent/US7553842B2/en not_active Expired - Fee Related
- 2006-01-19 MX MX2007008662A patent/MX2007008662A/es not_active Application Discontinuation
- 2006-01-19 JP JP2007552233A patent/JP2008528491A/ja not_active Withdrawn
- 2006-01-19 WO PCT/US2006/001747 patent/WO2006078724A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006206525A2 (en) | 2006-07-27 |
| TW200637552A (en) | 2006-11-01 |
| EP1838316A4 (en) | 2012-01-25 |
| WO2006078724A3 (en) | 2008-01-24 |
| US20060160838A1 (en) | 2006-07-20 |
| EP1838316A2 (en) | 2007-10-03 |
| US7553842B2 (en) | 2009-06-30 |
| JP2008528491A (ja) | 2008-07-31 |
| WO2006078724A2 (en) | 2006-07-27 |
| CA2601380A1 (en) | 2006-07-27 |
| MX2007008662A (es) | 2007-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022271425B2 (en) | Processes of making and crystalline forms of a MDM2 inhibitor | |
| EP3893871B1 (en) | Benzimidazolone derivatives, and analogues thereof, as il-17 modulators | |
| CN112566916B (zh) | 作为pad4抑制剂的经取代的噻吩并吡咯 | |
| CA2860187C (en) | Cyclic amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase and uses thereof | |
| CN112300153B (zh) | 一种杂环化合物、药物组合物和用途 | |
| EP3884939B1 (en) | 3-phosphoglycerate dehydrogenase inhibitors and uses thereof | |
| US8835633B2 (en) | Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives | |
| EA016199B1 (ru) | Соединения и композиции как ингибиторы активирующей канал протеазы | |
| AU2008250254A1 (en) | New cyclic peptide compounds | |
| CA3170664A1 (en) | P2x3 modulators | |
| CA2901770A1 (en) | Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors | |
| TW202411219A (zh) | 雜環化合物ccr4抑制劑及其用途 | |
| US7226906B2 (en) | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases | |
| US7553842B2 (en) | Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases | |
| US20060035821A1 (en) | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases | |
| EP4634156A1 (en) | Sarm1 modulators, preparations, and uses thereof | |
| CN117447460A (zh) | 作为ripk1抑制剂的杂环化合物 | |
| JP2010514732A (ja) | 安定なs‐ニトロソチオール類、その合成方法および使用 | |
| EP0292923A2 (en) | Piperidine compounds and pharmaceutical uses thereof | |
| CN116143661B (zh) | β-榄香烯不对称取代衍生物及其制备和用途 | |
| EP4219501A1 (en) | Compound containing 2,4-thiazole ring, preparation method therefor, and application thereof | |
| WO1999067239A1 (en) | Pyrazolopyridine compounds and medicinal uses thereof | |
| WO2024220874A2 (en) | Otub1 small-molecule binders and otub1-recruiting deubiquitinase-targeting chimeras (dubtacs) | |
| CN122003422A (zh) | 杂环pad4抑制剂 | |
| HK40096020A (en) | Mtorc1 modulators and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20 AUG 2007 |
|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |